Gelteq Ltd
GELS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001920092
No open-market purchases or sales by Gelteq Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $73.3K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Gelteq Ltd changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 6 | 6 | 0 |
| Shares | 105.8K | 94.1K | −11.7K (−11.1%) |
| Value | $183.1K | $129.6K | −$53.5K (−29.2%) |
New holders (2)
Institutions that held Gelteq Ltd at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 41,550 | $57.3K | 0.00% |
| Morgan Stanley | 651 | $898 | 0.00% |
Sold out (2)
Institutions that held Gelteq Ltd at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Citadel Advisors LLC | 23,201 | $40.1K |
| Raymond James Financial Inc | 200 | $346 |